CRMD
CorMedix·NASDAQ
--
--(--)
--
--(--)
5.95 / 10
Netural
Fund flow metrics score 7.73/10, revealing robust fund flow characteristics. Beneficial block and Large trends are challenged by problematic overall, Small, Medium, and Extra-large signals, indicating positive capital movement. Analyst consensus points to overwhelmingly bullish analyst consensus with strong conviction. Distribution analysis: Strong Buy(75.0%), Buy(25.0%) among 4 research opinions, supported by 4.16 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
75%
Buy
25%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-23
InstitutionHC Wainwright & Co.
Times predicted4
Historical Win Rate50.0%
What is the market sentiment for CRMD?
- CRMD holds a Bearish analyst rating, with 75% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.95/10 (Netural).
